Does HSV-1-mediated mitochondrial DNA deletion causally contribute to AD pathogenesis?

OPEN

While the abstract notes that HSV-1 can delete mitochondrial DNA and this occurs in AD, the causal relationship remains unclear. Determining whether viral-induced mitochondrial dysfunction directly drives AD pathology versus being a secondary effect is crucial for therapeutic targeting. Gap type: open_question Source paper: Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: relevance to pathological-signalling cascades. (2008, Neurochem Int, PMID:18164103)

Priority: 0.77 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: Does HSV-1-mediated mitochondrial DNA deletion causally contribute to AD pathogenesis? is a 0.77 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Does HSV-1-mediated mitochondrial DNA deletion causally contribute to AD pathogenesis? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (18)

DNAGENESDNATumorDNACancerDNAEpigeneticDNAAls
▸ Show 13 more

associated with (4)

entities-rosADentities-atp7b-geneADentities-histone-methylationADDNAAlzheimer

biomarker for (1)

DNAAls

causes (1)

ROSDNA

expressed in (1)

DNAAls

inhibits (4)

DNAEpigeneticDNATumorDNACancerDNAAging

interacts with (4)

DNACancerDNAAmyotrophic Lateral SclerosisDNAAlsDNATumor

regulates (10)

DNAGENESDNASenescenceGENESDNADNAInflammationDNADna Methylation
▸ Show 5 more

therapeutic target (7)

DNAAmyotrophic Lateral SclerosisDNACardiovascularDNAAlzheimerDNACancerDNATumor
▸ Show 2 more
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps